Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Samalizumab |
Trade Name | |
Synonyms | ALXN6000 |
Drug Descriptions |
Samalizumab (ALXN6000) is a humanized antibody against CD200 which blocks CD200-CD200R interaction, resulting in enhanced immune response (Blood 2010 116:2465, PMID: 31443741). |
DrugClasses | |
CAS Registry Number | 1073059-33-2 |
NCIT ID | C77891 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cytarabine + Daunorubicin + Samalizumab | Cytarabine Daunorubicin Samalizumab | 0 | 1 |
Samalizumab | Samalizumab | 0 | 1 |